Inventor · disambiguated record
Leeladhar Sammatur
Also filed as: SAMMATUR LEELADHAR
8 granted patents·7 pending applications·11 citations·filing 2009–2022
80Inventor score
Top patents by PatentIndex Score
15 records- 0183US11260116B2Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Granted Mar 1, 2022·2 cites·22 claims
- 0279US10988500B2Lipid A mimics, methods of preparation, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Granted Apr 27, 2021·1 cites·22 claims
- 0379US10105435B2Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2012·Granted Oct 23, 2018·5 cites·20 claims
- 0476US11406705B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Granted Aug 9, 2022·2 cites·20 claims
- 0567US12042537B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsBIOVAXYS INC·Filed 2022·Granted Jul 23, 2024·0 cites·19 claims
- 0666US10533033B2Lipid A mimics, methods of preparation, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2015·Granted Jan 14, 2020·1 cites·35 claims
- 0765US11717563B2Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substanceIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Granted Aug 8, 2023·0 cites·26 claims
- 0865US11077184B2Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune responseIMMUNOVACCINE TECHNOLOGIES INC·Filed 2018·Granted Aug 3, 2021·0 cites·21 claims
- 0965US2011070298A1Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic SubstanceIMMUNOVACCINE TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 1064US2022143165A1Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1164US2021308252A1Liposome compositions comprising pam2cys or pam3cys adjuvant and methods for inducing a humoral immune responseIMMUNOVACCINE TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1248US2021147544A1Methods and compositions for targeted delivery of active agents and immunomodulatory agents to lymph nodesIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1343US2020230057A1Pharmaceutical Compositions, Methods for Preparation using Lipid Vesicle Particles of Defined Size, and Uses ThereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 1443US2020353062A1Pharmaceutical compositions, methods for preparation comprising sizing of lipid vesicle particles, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 1540US2018162913A1Methods for potentiating an immune response using depot-forming and non-depot-forming vaccinesIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →